Pro Medicus Ltd
ASX:PME
Intrinsic Value
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. [ Read More ]
The intrinsic value of one PME stock under the Base Case scenario is 20.37 AUD. Compared to the current market price of 107.92 AUD, Pro Medicus Ltd is Overvalued by 81%.
Valuation Backtest
Pro Medicus Ltd
Run backtest to discover the historical profit from buying and selling PME stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Pro Medicus Ltd
Current Assets | 176m |
Cash & Short-Term Investments | 130.4m |
Receivables | 42.5m |
Other Current Assets | 3.1m |
Non-Current Assets | 38.1m |
PP&E | 1.9m |
Intangibles | 20.7m |
Other Non-Current Assets | 15.5m |
Current Liabilities | 23.5m |
Accounts Payable | 1.2m |
Other Current Liabilities | 22.3m |
Non-Current Liabilities | 31.4m |
Long-Term Debt | 988k |
Other Non-Current Liabilities | 30.4m |
Earnings Waterfall
Pro Medicus Ltd
Revenue
|
146.2m
AUD
|
Cost of Revenue
|
-430k
AUD
|
Gross Profit
|
145.8m
AUD
|
Operating Expenses
|
-45.5m
AUD
|
Operating Income
|
100.3m
AUD
|
Other Expenses
|
-30.6m
AUD
|
Net Income
|
69.7m
AUD
|
Free Cash Flow Analysis
Pro Medicus Ltd
PME Profitability Score
Profitability Due Diligence
Pro Medicus Ltd's profitability score is 93/100. The higher the profitability score, the more profitable the company is.
Score
Pro Medicus Ltd's profitability score is 93/100. The higher the profitability score, the more profitable the company is.
PME Solvency Score
Solvency Due Diligence
Pro Medicus Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Pro Medicus Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PME Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PME is 92.21 AUD with a low forecast of 58.44 AUD and a high forecast of 126 AUD.
Shareholder Return
PME Price
Pro Medicus Ltd
Average Annual Return | 35.1% |
Standard Deviation of Annual Returns | 42.07% |
Max Drawdown | -61% |
Market Capitalization | 11.3B AUD |
Shares Outstanding | 104 738 514 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. The company is headquartered in Richmond, Victoria. The company went IPO on 2000-10-10. The firm products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information Systems (RIS) medical software for practicing of management, training, installation and professional services, after sale support and service products, Promedicus.net secure email and Integration products. Its Visage 7.0 is a healthcare imaging software that provides radiologists and clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images, Picture Archive and Communication System (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and professional services and support products.
Contact
IPO
Employees
Officers
The intrinsic value of one PME stock under the Base Case scenario is 20.37 AUD.
Compared to the current market price of 107.92 AUD, Pro Medicus Ltd is Overvalued by 81%.